Energy restriction ameliorates metabolic syndrome-induced cavernous tissue structural modifications in aged rats

Age

Volumn 35, Issue 5, 2013, Pages 1721-1739

  Tomada, Inês ^a   Fernandes, Dalila ^a   Guimarães, João Tiago ^a,b   Almeida, Henrique ^a   Neves, Delminda ^a  

^a University of Porto   (Portugal)

^b Universidade do Porto   (Portugal)

Author keywords

Adiponectin; Aging; Cavernous tissue; Energy restriction; High fat diet; Metabolic syndrome

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; COLLAGEN; INSULIN;

AGING; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CALORIC RESTRICTION; CONTROLLED STUDY; CORPUS CAVERNOSUM; HEART MUSCLE; HYPERLIPIDEMIA; HYPERTENSION; HYPOADIPONECTINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RAT;

ADIPONECTIN; ADIPOSE TISSUE; AGING; ANIMALS; COLLAGEN; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENERGY INTAKE; ERECTILE DYSFUNCTION; MALE; METABOLIC SYNDROME X; PENIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84892580650     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-012-9473-z     Document Type: Article

References (68)

1. Aziz AA, Kenney LS, Goulet B, Abdel-Aal ES (2009) Dietary starch type affects body weight and glycemic control in freely fed but not energy-restricted obese rats. J Nutr 139:1881-1889
2. Barandier C, Montani JP, Yang Z (2005) Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity. Am J Physiol Heart Circ Physiol 289:H1807-H1813
3. Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L (1998) Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 101:1353-1361
4. Berk BC, Fugiwara K, Lehoux S (2007) ECM remodelling in hypertensive heart disease. J Clin Invest 117:568-575
5. Billups KL, Bank AJ, Padma-Nathan H, Katz SD, Williams RA (2008) Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res 20:236-242
6. Blouet C, Mariotti F, Azzout-Marniche D, Bos C, Mathé V, Tomé D, Huneau JF (2006) The reduced energy intake of rats fed a high-protein low-carbohydrate diet explains the lower fat deposition, but macronutrient substitution accounts for the improved glycemic control. J Nutr 136:1849-1854
7. Blüher M, Kahn BB, Kahn CR (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299:572-574
8. Boneti P, Lerman L, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Atheroscler Thromb Vasc Biol 23:168-175
9. Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schölmerich J, Bollheimer LC (2006) Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 36:485-501
10. Burchard T, Burchard M, Karden J, Buttyan R, Shabsigh A, de La Taille A, Ng PY, Anastasiadis AG, Shabsigh R (2000) Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat. J Urol 164:1807-1811
11. Cacho J, Sevillano J, Castro J, Herrera E, Ramos MP (2008) Validation of simple indexes to assess insulin sensibility during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 295:E1269-E1276
12. Camici GG, Shi Y, Cosentino F, Francia P, Lüscher TF (2011) Anti-aging medicine: molecular basis for endothelial celltargeted strategies-a mini-review. Gerontology 57:101-108
13. Carrier S, Nagaraju P, Morgan DM, Baba K, Nunes L, Lue TF (1997) Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J Urol 157:1088-1092
14. Chew KK, Finn J, Stuckey B, Gibson N, Sanfilippo F, Bremner A, Thompson P, HobbsM, Jamrozik K (2010) Erectile dysfunction as a predictor for subsequent atherosclerotic events: findings from a linked-data study. J Sex Med 7:192-202
15. Di Chiara T, Argano C, Corrao S, Scaglione R, Licata G (2012) Hypoadiponectinemia: a link between visceral obesity and matabolic syndrome. J Nutr Metab 2012:175245
16. Dong JY, Zhang YH, Qin LQ (2011) Erectile dysfunction and risk of cardiovascular disease. J Am Coll Cardiol 58:1378-1385
17. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychossocial correlates: results from theMassachusettsMale Aging Study. J Urol 151:54-61
18. Fernandez CD, Bellentani FF, Fernandes GS, Perobelli JE, Favareto AP, Nascimento AF, Cicogna AC, Kempinas WD (2011) Diet-induced obesity in rats leads to a decrease in sperm motility. Reprod Biol Endocrinol 9:32
19. Ferrini MG, Kovanecz I, Sanchez S, Umeh C, Rajfer J, Gonzalez-Cadavid NF (2009) Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal venoocclusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in rat. J Sex Med 6:415-428
20. Fontana L, Meyer TE, Klein S, Holloszy JO (2004) Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A 101:6659-6663
21. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359
22. Frederiksen L, Højlund K, Hougaard DM, Brixen K, Andersen M (2012) Testosterone therapy increased muscle mass and lipid oxidation in aging men. Age (Dordr) 34:145-156
23. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative centrifuge. Clin Chem 18:499-502
24. Grundy G (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92:399-404
25. Hausman DB, Fine JB, Tagra K, Fleming SS, Martin RJ, DiGirolamo M (2003) Regional fat pad growth and cellularity in obese Zucker rats: modulation by caloric restriction. Obes Res 11:674-682
26. G HB, Rao VS, Kakkar VV (2011) Friend turns foe: transformation of anti-inflammatory HDL to proinflammatory HDL during acute-phase response. Cholesterol 2011:274629
27. Jackson G (2008) Prevention of cardiovascular disease by the early identification of erectile dysfunction. Int J Impot Res 20(suppl2):S9-S14
28. Jackson G, Rosen RC, Kloner RA, Kostis JB (2006) The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 3:28-36
29. Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Blaak EE, Feskens EJ, Jansen EH, Schalkwijk CG, Stehouwer CD (2011) The association between themetabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study. Eur J Clin Investig 41:167-175
30. Jiang R, Chen JH, Jun J, Shen W, Li QM (2005) Ultrastructural comparison of penile cavernous tissue between hypertensive and normotensive rats. Int J Impot Res 17:417-423
31. Jones TH (2007) Testosterone associations with erectile dysfunction, diabetes, and the metabolic syndrome. Eur Urol 6:847-857
32. Kadowaki T, Yamauchi T, Kubota N (2008) The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 582:74-80
33. Karbowska J, Kochan Z (2006) Role of adiponectin in the regulation of carbohydrate and lipid metabolism. J Physiol Pharmacol 57:103-113
34. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G (2003) Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52:1779-1785
35. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW (2008) Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 28:1982-1988
36. Kirby M, Jackson G, Betterridge J, Friedli K (2001) Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 55:614-618
37. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson C, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R (2005) Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 96:313-321
38. Kressel G, Trunz B, Bub A, Hülsmann O, Wolters M, Lichtinghagen R, Stichtenoth DO, Hahn A (2009) Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerotic risk. Atherosclerosis 202:263-271
39. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y (2003) Association of adiponectiemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89
40. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality inmiddle-aged men. JAMA 288:2709-2716
41. Laughlin GA, Barrett-Connor E, Bergstrom J (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93:68-75
42. Leal S, Sá C, Gonçalves J, Fresco P, Diniz C (2008) Immunohistochemical characterization of adenosine receptors in rat aorta and tail artery. Microsc Res Tech 71:703-709
43. Martin B, Ji S, Maudsley S, Mattson MP (2010) "Control" laboratory rodents are metabolically morbid: why it matters. PNAS 107:6127-6133
44. Marx N, Grant PJ (2007) Endothelial dysfunction and cardiovascular disease-the lull before the storm. Diab Vasc Dis Res 4:82-83
45. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y (2002) Role of adiponectin in preventing vascular stenosis. The missing link of adipovascular axis. J Biol Chem 277:37487-37491
46. Montorsi P, Montorsi F, Schullman CC (2003) Is erectile dysfunction the "tip of iceberg" of a systemic vascular disease? Eur Urol 44:352-354
47. Montorsi P, Ravagnani PM, Galli S, Salonia A, Briganti A, Werba JP, Montorsi F (2006) Association between erectile dysfunction and coronary artery disease: matching the right target with the right test in the right patient. Eur Urol 50:721-731
48. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM (1996) The Yin and Yang of oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 16:831-842
49. Neves D, Santos J, Tomada N, Almeida H, Vendeira P (2006) Aging and orchidectomy modulate expression of VEGF receptors (Flt-1 and Flk-1) on corpus cavernosum of the rat. Ann N Y Acad Sci 1067:164-172
50. Neves D, Tomada I, Assunção M, Marques F, Almeida H, Andrade JP (2010) Effects of chronic red wine consumption on the expression of vascular endothelial growth factor, angiopoietin 1, angiopoietin 2, and its receptors in rat erectile tissue. J Food Sci 75(3):H79-H86
51. NIH Consensus Conference (1993) Impotence. NIH Consensus Development Panel on Impotence. JAMA 270:83-90
52. Onat A, Can G, Kaya H, Hergenç G (2010) "Atherogenic index of plasma" (log10 triglyceride/high-density lipoproteincholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 4:89-98
53. Pajvani UB, Scherer PE (2003) Adiponectin: systemic contributor to insulin sensitivity. Curr Diabetes Rep 3:207-213
54. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease. Circulation 107:499-511
55. Picard F, Guarente L (2005) Molecular links between aging and adipose tissue. Int J Obes 29:S36-S39
56. Razny U, Kiec-Wilk B, Wator L, Polus A, Dyduch G, Solnica B, Malecki M, Tomaszewska R, Cooke JP, Dembinska-Kiec A (2011) Increased nitric oxide availability attenuates high fat diet metabolic alterations and gene expression associated with insulin resistance. Cardiovasc Diabetol 10:68-81
57. Rizvi AA (2009) Cytokine biomarkers, endothelial inflammation, and atherosclerosis in the metabolic syndrome: emerging concepts. Am J Med Sci 338:310-318
58. Rodriguez JJ, Al Dashti R, Schwarz ER (2005) Linking erectile dysfunction and coronary artery disease. Int J Impot Res 17 (suppl1):S12-S18
59. Shen ZJ, Jin XD, Chen ZD, Shi YH (2001) Effect of aging on penile ultrastructure. Asian J Androl 3:281-284
60. ShimabukuroM, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, Ueda S, Shimomura I, Funahashi T, Matsuzawa Y (2003) Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 88:3236-3240
61. Shin D, Pregenzer G, Gardin JM (2011) Erectile dysfunction. A disease marker for cardiovascular disease. Cardiol Rev 19 (1):5-11
62. Sinclair DA (2005) Toward a unified theory of caloric restriction and longevity regulation. Mech Aging Dev 126:987-1002
63. Souza FM, Padilha AS, Stefanon I, Vassallo DV (2008) Differences in functional and structural properties of segments of the rat tail artery. Braz J Med Biol Res 41:416-423
64. Sweazea KL, Lekic M, Walker BR (2010) Comparison of mechanisms involved in impaired vascular reactivity between high sucrose and high fat diets in rats. Nutr Metab 7:48-57
65. Tomada I, Tomada N, Almeida H, Neves D (2011) Androgen depletion in humans leads to cavernous tissue reorganization and upregulation of Sirt1-eNOS axis. Age (Dordr). doi:10.1007/s11357-011-9328-z
66. Traish AM, Goldstein I, Kim NN (2007) Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 52:54-70
67. Vikan T, Schirmer H, Njolstad I, Svatberg J (2009) Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso Study. Eur J Endocrinol 161:435-442
68. Ye J, Keller JN (2010) Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction. Aging 2:361-368